Inflammatory bowel disease (IBD) is heterogenous group of inflammatory disorders characterized by chronic immune activation and inflammation of the gastrointestinal tract, associated with numerous extraintestinal manifestations. Two most important forms are Crohn's disease and ulcerative colitis with several phenotypes. Etiopathogenesis of IBD is still unknown. Diagnostic and therapeutic approach of IBD is very complex and requires excellent knowledge of the clinical course and complications of the disease itself and therapy. The paper provides present therapeutic strategy with emphasis on the importance of mucosal healing and analysis of present knowledge of the role of biologics in the therapy of IBD.
炎症性肠病(IBD)是一组异质性炎症性疾病,其特征为胃肠道的慢性免疫激活和炎症,并伴有多种肠外表现。两种最重要的形式是克罗恩病和溃疡性结肠炎,它们具有多种表型。IBD的病因发病机制仍不清楚。IBD的诊断和治疗方法非常复杂,需要对疾病本身的临床病程和并发症以及治疗有深入的了解。本文提供了当前的治疗策略,重点强调了黏膜愈合的重要性,并分析了生物制剂在IBD治疗中作用的现有知识。